4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001079973-25-001809
Chief Executive Officer acquired 6,464 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virnich Daniel Chief Executive Officer | 2025-11-17 | Grant or award | +6,464 | 1,799,984 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…